Among these, drugs targeting a specific receptor or channel at the transmembrane level have proven effectiveness, bringing them to the level of major therapeutic approaches such as fluoxetine for treating depression and GLP-1 as an antidiabetic. Here, GLP1R is linked to depressive disorder.